Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays
G D Carter1, J L Berry, E Gunter
1Clinical Biochemistry, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK. b.carter1@which.net
The Journal of Steroid Biochemistry and Molecular Biology
|March 23, 2010
Summary
The Vitamin D External Quality Assessment Scheme (DEQAS) improved 25-hydroxyvitamin D (25-OHD) assay precision significantly since 1994. DEQAS continues to monitor assay performance, ensuring reliable vitamin D testing globally.
Area of Science:
- Clinical Chemistry
- Laboratory Medicine
- Endocrinology
Background:
- The Vitamin D External Quality Assessment Scheme (DEQAS) has monitored 25-hydroxyvitamin D (25-OHD) assay performance since 1989.
- DEQAS has experienced rapid growth, serving 670 participants across 35 countries as of July 2009.
Purpose of the Study:
- To assess and improve the performance of 25-OHD assays through external quality assessment.
- To track trends in inter-laboratory imprecision and accuracy for vitamin D measurements.
Main Methods:
- Distribution of five human serum samples quarterly to participating laboratories.
- Analysis of participant results to determine the All-Laboratory Trimmed Mean (ALTM) and standard deviation (SD).
- Provision of preliminary and final reports to participants via the internet and email.
Main Results:
- Significant improvement in mean inter-laboratory imprecision (CV) from 32.0% in 1994 to 15.3% in 2009.
- As of 2009, most major methods achieved results within ±7.4% of the ALTM.
- DEQAS has conducted numerous investigations into the performance of various 25-OHD methods.
Conclusions:
- DEQAS has demonstrably improved the precision of 25-OHD assays over the past 15 years.
- A gas chromatography-mass spectrometry (GC-MS) reference method is under development to further validate assay performance.
- The suitability of the ALTM as the primary target for DEQAS samples will be evaluated using the new reference method.

